37140 Federal Register / Vol. 63, No. 131 /Thursday, July 9, 1998 / Notices

The firm plans to import small

quantities of the listed controlled

substance to manufacture laboratory

reference standards and

neurochemicals.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than

September 8, 1998.

Dated: June 30, 1998.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–18222 Filed 7–8–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on April 1, 1998, Research

Biochemicals, Inc., which has changed

its name to Sigma-Aldrich Research

Biochemicals, Inc., One Three

Strathmore Road, Attn: Richard A.

Milius PhD, Natick, Massachusetts

01760, made application to the Drug

Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Methaqualone (2565) ................... I

Ibogaine (7260) ............................ I

Tetrahydrocannabinols (7370) ...... I

Bufotenine (7433) ......................... I

Drug Schedule

Dimethyltryptamine (7435) ........... I

Etorphine (except HC1) (9056) .... I

Methylphenidate (1724) ................ II

Pentobarbital (2270) ..................... II

Diprenorphine (9058) .................... II

Etorphine Hydrochloride (99059) II

Diphenoxylate (9170) ................... II

Metazocine (9240) ........................ II

Methadone (9250) ........................ II

Fentanyl (9801) ............................ II

The firm plans to import small

quantities of the listed controlled

substances to manufacture laboratory

reference standards and

neurochemicals.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, D.C.

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than August 10, 1998.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import basic classes of

any controlled substances in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: June 24, 1998.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–18223 Filed 7–8–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on March 31, 1998, Research

Triangle Institute, Kenneth H. Davis, Jr.,

Hermann Building, East Institute Drive,

P.O. Box 12194, Research Triangle Park,

North Carolina 27709, made application

by renewal to the Drug Enforcement

Administration to be registered as an

importer of the basic classes of

controlled substances listed below:

Drug Schedule

Marihuana (7360) ......................... I

Cocaine (9041) ............................. II

The firm plans to import small

quantities of the listed controlled

substances for the National Institute of

Drug Abuse and other clients.

Any manufacturer holding, or

applying, for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, D.C.

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than August 10, 1998.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import the basic classes
Federal Register / Vol. 63, No. 131 /Thursday, July 9, 1998 / Notices 37141

of any controlled substances in

Schedule I or II are and will continue to

be required to demonstrate to the

Deputy Assistant Administrator, Office

of Diversion Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: June 10, 1998.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–18215 Filed 7–8–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Immigration and Naturalization Service

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Notice of Information

Collection Under Review; Data Relating

to Beneficiary of Private Bill.

The Department of Justice,

Immigration and Naturalization Service

has submitted the following information

collection request for review and

clearance in accordance with the

Paperwork Reduction Act of 1995. The

proposed information collection is

published to obtain comments from the

public and affected agencies. Comments

are encouraged and will be accepted for

‘‘sixty days’’ until September 8, 1998.

Written comments and suggestions

from the public and affected agencies

concerning the proposed collection of

information should address one or more

of the following four points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agencies estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Overview of this information

collection:

(1) Type of Information Collection:

Extension of a currently approved

collection.

(2) Title of the Form/Collection: Data

Relating to Beneficiary of Private Bill.

(3) Agency form number, if any, and

the applicable component of the

Department of Justice sponsoring the

collection: Form G–79A. Investigations

Division, Immigration and

Naturalization Service.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Primary: Individuals or

Households. The information is needed

to report on Private Bills to Congress

when requested.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond: 100 responses at 1 Hour per

response.

(6) An estimate of the total public

burden (in hours) associated with the

collection: 100 annual burden hours.

If you have additional comments,

suggestions, or need a copy of the

proposed information collection

instrument with instructions, or

additional information, please contact

Richard A. Sloan 202–514–3291,

Director, Policy Directives and

Instructions Branch, Immigration and

Naturalization Service, U.S. Department

of Justice, Room 5307, 425 I Street, NW.,

Washington, DC 20536. Additionally,

comments and/or suggestions regarding

the item(s) contained in this notice,

especially regarding the estimated

public burden and associated response

time may also be directed to Mr.

Richard A. Sloan.

If additional information is required

contact: Mr. Robert B. Briggs, Clearance

Officer, United States Department of

Justice, Information Management and

Security Staff, Justice Management

Division, Suite 850, Washington Center,

1001 G Street, NW., Washington, DC

20530.

Dated: July 1, 1998.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 98–18241 Filed 7–8–98; 8:45 am]

BILLING CODE 4410–18–M

DEPARTMENT OF JUSTICE

Immigration and Naturalization Service

Agency Information Collection

Activities: Proposed Collection;

Comment Request

ACTION: Notice of Information Collection

Under Review; Biographic Information.

The Department of Justice,

Immigration and Naturalization Service

has submitted the following information

collection request for review and

clearance in accordance with the

Paperwork Reduction Act of 1995. The

proposed information collection is

published to obtain comments from the

public and affected agencies. Comments

are encouraged and will be accepted for

‘‘sixty days’’ until September 8, 1998.

Written comments and suggestions

from the public and affected agencies

concerning the proposed collection of

information should address one or more

of the following four points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agencies’ estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

response.

Overview of this information

collection:

(1) Type of Information Collection:

Extension of a currently approved

collection.

(2) Title of the Form/Collection:

Biographic Information.

(3) Agency form number, if any, and

the applicable component of the

Department of Justice sponsoring the

collection: Form G–325. Adjudications

Division, Immigration and

Naturalization Service.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Primary: Individuals or

Households. This form is used when it

is necessary to check other agency

records on applications or petitions

submitted by applicants for benefits